Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jul. 31, 2018 |
Jul. 31, 2017 |
Jul. 31, 2018 |
Jul. 31, 2017 |
|
| Revenues: | ||||
| Total revenues | $ 11,901,000 | $ 17,225,000 | $ 26,836,000 | $ 33,892,000 |
| Cost of revenues: | ||||
| Amortization of intangible assets | 178,000 | 255,000 | 356,000 | 509,000 |
| Stock-based compensation expense | (1,000) | 2,000 | ||
| Total cost of revenues | 5,615,000 | 5,809,000 | 11,644,000 | 12,599,000 |
| Gross profit | 6,286,000 | 11,416,000 | 15,192,000 | 21,293,000 |
| Operating expenses: | ||||
| Research and development | 5,157,000 | 6,399,000 | 10,641,000 | 11,777,000 |
| Selling and marketing | 3,685,000 | 2,439,000 | 7,071,000 | 5,376,000 |
| General and administrative | 4,021,000 | 3,084,000 | 8,015,000 | 6,727,000 |
| Amortization of intangible assets | 233,000 | 361,000 | 459,000 | 705,000 |
| Stock-based compensation expense | 924,000 | 653,000 | 1,802,000 | 1,528,000 |
| Professional fees - other | 21,000 | |||
| Severance and other restructuring costs | 536,000 | 563,000 | 590,000 | 2,710,000 |
| Total operating expenses | 14,556,000 | 13,499,000 | 28,578,000 | 28,844,000 |
| Loss from operations | (8,270,000) | (2,083,000) | (13,386,000) | (7,551,000) |
| Other (expenses) income, net | (1,962,000) | 589,000 | (2,811,000) | 955,000 |
| Loss before income taxes | (10,232,000) | (1,494,000) | (16,197,000) | (6,596,000) |
| Income tax (benefit) provision | (1,152,000) | 35,000 | (1,646,000) | 304,000 |
| Net loss | (9,080,000) | (1,529,000) | (14,551,000) | (6,900,000) |
| Net loss | (9,080,000) | (1,529,000) | (14,551,000) | (6,900,000) |
| Other comprehensive (loss) income, net of tax: | ||||
| Foreign currency translation adjustment | 856,000 | 83,000 | 1,431,000 | 3,000 |
| Unrealized gain (loss) on marketable securities | 11,000 | 3,000 | (18,000) | (5,000) |
| Comprehensive loss | $ (8,213,000) | $ (1,443,000) | $ (13,138,000) | $ (6,902,000) |
| Net loss per share: | ||||
| Basic | $ (0.26) | $ (0.05) | $ (0.41) | $ (0.20) |
| Diluted | $ (0.26) | $ (0.05) | $ (0.41) | $ (0.20) |
| Weighted average common shares outstanding: | ||||
| Basic | 35,649 | 35,351 | 35,628 | 35,331 |
| Diluted | 35,649 | 35,351 | 35,628 | 35,331 |
| Product [Member] | ||||
| Revenues: | ||||
| Total revenues | $ 1,462,000 | $ 5,039,000 | $ 4,553,000 | $ 7,788,000 |
| Cost of revenues: | ||||
| Cost of revenues | 483,000 | 1,336,000 | 802,000 | 1,890,000 |
| Service [Member] | ||||
| Revenues: | ||||
| Total revenues | 10,439,000 | 12,186,000 | 22,283,000 | 26,104,000 |
| Cost of revenues: | ||||
| Cost of revenues | $ 4,955,000 | $ 4,218,000 | $ 10,486,000 | $ 10,198,000 |
| X | ||||||||||
- Definition The amortization of intangible assets allocated to cost of revenues. No definition available.
|
| X | ||||||||||
- Definition The value represents expense of stock based compensation allocated to cost of revenue. No definition available.
|
| X | ||||||||||
- Definition Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|